Results 191 to 200 of about 22,234 (251)

Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children and Adolescents Aged 6-17 Years. [PDF]

Am J Trop Med Hyg, 2020
McCarty JM, Gierman EC, Bedell L, Lock MD, Bennett S.   +4 more
europepmc   +1 more source

Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomized, placebo-controlled trial

Leitner DR, Walsh SR, Suzuki M, Desjardins M, Hannaford A, Sherman AC, Levine H, Carr L, Hammerness E, Osaki A, Sullivan E, Wang B, Balazs GI, Park Chang JB, Slater DM, Puri N, Kuehl CJ, Chen WH, Harris JB, Piantadosi S, Baden LR, Waldor MK.   +21 more
europepmc   +1 more source

Killed oral cholera vaccines: from concept to public health reality

, 2012
John D. Clemens
openalex   +1 more source

Use of Oral Cholera Vaccine and Knowledge, Attitudes, and Practices Regarding Safe Water, Sanitation and Hygiene in a Long-Standing Refugee Camp, Thailand, 2012-2014

, 2016
Heather M. Scobie, Christina R. Phares, Kathleen Wannemuehler, Edith Nyangoma, Eboni M. Taylor, Anna C. Fulton, Nuttapong Wongjindanon, Naw Rody Aung, Phillipe Travers, Kashmira Date   +9 more
openalex   +2 more sources

Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trial [PDF]

Deborah R. Leitner, Stephen R. Walsh, Masataka Suzuki, Michaël Desjardins, Alisse Hannaford, Amy C Sherman, Hannah Levine, Lena Carr, Elliot Hammerness, Akina Osaki, Emily Sullivan, Bryan Wang, George I Balazs, Jun Bai Park Chang, Damien Slater, Nirajan Puri, Carole J. Kuehl, Wilbur H. Chen, J. B. Harris, Steven Piantadosi, Lindsey R. Baden, Matthew K. Waldor, August Heithoff, Katherine G Dailey, Ruchika Dehinwal, Alexander A. Morano, Kimberly Dufresne, L Parisi, Aidan Eustace, Bonnie Piantadosi, Xiaofang Li   +30 more
openalex   +1 more source

Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial. [PDF]

Int J Epidemiol, 2019
Ali M, Qadri F, Kim DR, Islam T, Im J, Ahmmed F, Chon Y, Islam Khan A, Zaman K, Marks F, Clemens JD.   +10 more
europepmc   +1 more source

Effectiveness of a single dose of oral cholera vaccine: findings from epidemiological and genomic surveillance ofVibrio Choleraein the Democratic Republic of the Congo (PICHA7 Program)

George CM, Namunesha A, Endres K, Felicien W, Sanvura P, Bisimwa J, Perin J, Bengehya J, Maheshe G, Cikomola C, Bisimwa L, Mwishingo A, Sack DA, Domman D.   +13 more
europepmc   +1 more source

Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity [PDF]

, 2018
Ciorba, Matthew A, et al,, Fleckenstein, James M, Kuhlmann, F. M, Kumar, Pardeep, Polino, Alexander, Santhanam, Srikanth, Sheikh, Alaullah, Tumala, Brunda, Vickers, Tim J   +9 more
core   +1 more source

Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.

Lancet Glob Health
Song KR, Chapagain RH, Tamrakar D, Shrestha R, Kanodia P, Chaudhary S, Wartel TA, Yang JS, Kim DR, Lee J, Park EL, Cho H, Lee J, Thaisrivichai P, Vemula S, Kim BM, Gupta B, Saluja T, Pansuriya RK, Ganapathy R, Baik YO, Lee YJ, Jeon S, Park Y, Her HL, Park Y, Lynch JA.   +26 more
europepmc   +1 more source

Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera. [PDF]

PLoS Negl Trop Dis, 2019
Im J, Islam MT, Ahmmed F, Kim DR, Chon Y, Zaman K, Khan AI, Ali M, Marks F, Qadri F, Clemens JD.   +10 more
europepmc   +1 more source